Advantages of low molecular weight heparin over standard heparin: facts and fiction.
Vinazzer
H
H
Blood Coagulation Laboratory, Linz, Austria.
D004341:Drug Evaluation; D015949:Factor IXa / Q000037:antagonists & inhibitors; D065427:Factor Xa Inhibitors; D006493:Heparin / Q000009:adverse effects / Q000494:pharmacology*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D011516:Prothrombin / Q000037:antagonists & inhibitors; D013917:Thrombin / Q000037:antagonists & inhibitors
D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D011516:Prothrombin; C025337:Factor IIa; D006493:Heparin; D015949:Factor IXa; D013917:Thrombin